1. Home
  2. NINE vs LIXT Comparison

NINE vs LIXT Comparison

Compare NINE & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nine Energy Service Inc.

NINE

Nine Energy Service Inc.

HOLD

Current Price

$0.33

Market Cap

27.5M

Sector

Energy

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.80

Market Cap

25.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NINE
LIXT
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5M
25.4M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
NINE
LIXT
Price
$0.33
$3.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1M
98.1K
Earning Date
10-30-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$571,171,000.00
N/A
Revenue This Year
$4.56
N/A
Revenue Next Year
$1.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.59
N/A
52 Week Low
$0.29
$0.64
52 Week High
$1.78
$6.26

Technical Indicators

Market Signals
Indicator
NINE
LIXT
Relative Strength Index (RSI) 36.72 40.41
Support Level $0.29 $4.01
Resistance Level $0.51 $4.31
Average True Range (ATR) 0.04 0.29
MACD -0.00 -0.02
Stochastic Oscillator 19.37 38.95

Price Performance

Historical Comparison
NINE
LIXT

About NINE Nine Energy Service Inc.

Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: